5-Bromoimidazo[1,2-A]Pyrazine

CAS No. 87597-26-0

5-Bromoimidazo[1,2-A]Pyrazine( —— )

Catalog No. M37011 CAS No. 87597-26-0

5-Bromoimidazo[1,2-a]pyrazine inhibits phosphodiesterase and beta-adrenergic receptors.5-Bromoimidazo[1,2-a]pyrazine shows antibronchospastic activity in vitro.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 172 In Stock
10MG 254 In Stock
25MG 392 In Stock
50MG 531 In Stock
100MG 710 In Stock
200MG 958 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    5-Bromoimidazo[1,2-A]Pyrazine
  • Note
    Research use only, not for human use.
  • Brief Description
    5-Bromoimidazo[1,2-a]pyrazine inhibits phosphodiesterase and beta-adrenergic receptors.5-Bromoimidazo[1,2-a]pyrazine shows antibronchospastic activity in vitro.
  • Description
    5-Bromoimidazo[1,2-a]pyrazine inhibits phosphodiesterase and beta-adrenergic receptors.5-Bromoimidazo[1,2-a]pyrazine shows antibronchospastic activity in vitro.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Adrenergic Receptor
  • Recptor
    Adrenergic Receptor | PDE
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    87597-26-0
  • Formula Weight
    198.02
  • Molecular Formula
    C6H4BrN3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    BrC1=CN=CC2=NC=CN12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • ST 91

    ST-91 is an agonist of α2-adrenoceptor with a mixed α-adrenergic receptor type/subtype selection profile.

  • Tolamolol

    Tolamolol is a selective β-adrenergic blocker that significantly reduces the degree of exercise-induced inhibition of the S-T segment and can be used in the treatment of cardiac arrhythmias.

  • AR-08

    AR-08 is a potent α2-adrenergic receptor agonist for the study of ADHD and attention deficit.